Alseres Pharmaceuticals, Inc. (ALSE)
USD 0.01
(100.0%)
USD 0.01
(100.0%)
| Breakdown | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Revenue | 473.73 Thousand | 530.72 Thousand | - | - | - | - |
| Cost of Revenue | 23.68 Thousand | - | - | - | - | - |
| Gross Profit | 450.04 Thousand | 530.72 Thousand | - | - | - | - |
| Operating Expenses | 1.41 Million | 1.71 Million | 1.56 Million | 3.12 Million | 8.32 Million | 18.71 Million |
| Selling, General and Administrative Expenses | 1.41 Million | 1.66 Million | 2.03 Million | 2.65 Million | 4.62 Million | 7.85 Million |
| Research and Development Expenses | - | 50.75 Thousand | 93.31 Thousand | 465.44 Thousand | 3.7 Million | 10.85 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.41 Million | 1.71 Million | 1.56 Million | 3.12 Million | 8.32 Million | 18.71 Million |
| Operating Income | -564.72 Thousand | -1.21 Million | -1.56 Million | -3.12 Million | -8.32 Million | -18.71 Million |
| Interest Expense | 454.66 Thousand | 434.55 Thousand | 1.83 Million | 2.64 Million | 2.52 Million | 2.21 Million |
| Income Tax Expense | 454.66 Thousand | 434.55 Thousand | 1.31 Million | -3.63 Million | 2.45 Million | 2.13 Million |
| Earnings before Tax | -941.52 Thousand | -1.64 Million | -1.04 Million | 3.15 Million | -8.25 Million | -18.63 Million |
| Net Income | -941.52 Thousand | -1.64 Million | -2.88 Million | 512.41 Thousand | -10.77 Million | -20.84 Million |
| Earnings Per Share Basic | -153.67 | -268.56 | -486.45 | 50.00 | -2306.71 | -4992.21 |
| Earnings Per Share Diluted | -153.67 | -268.56 | -486.45 | 81.12 | -2306.71 | -4992.21 |
| Weighted Average Shares Outstanding | 6127.00 | 6127.00 | 5925.00 | 5337.00 | 4672.00 | 4176.00 |
| Weighted Average Shares Outstanding (Diluted) | 6127.00 | 6127.00 | 5925.00 | 6317.00 | 4672.00 | 4176.00 |
| Gross Margin | 0.95 | 1.00 | - | - | - | - |
| EBIT Margin | -1.99 | -2.23 | - | - | - | - |
| Profit Margin | -1.99 | -3.10 | - | - | - | - |
| EBITDA | -485.67 Thousand | -1.2 Million | -1 Million | 58.59 Thousand | -8.18 Million | -18.57 Million |
| Earnings Before Tax Margin | -1.19 | -2.28 | - | - | - | - |
| Breakdown | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 FY | 2013 Q3 | 2013 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 18.43 Thousand | 18.43 Thousand | 418.43 Thousand | 473.73 Thousand | 18.43 Thousand | 18.43 Thousand |
| Cost of Revenue | 921.00 | 922.00 | 23.68 Thousand | 23.68 Thousand | - | - |
| Gross Profit | 17.51 Thousand | 17.51 Thousand | 394.74 Thousand | 450.04 Thousand | 18.43 Thousand | 18.43 Thousand |
| Operating Expenses | 334.63 Thousand | 348.15 Thousand | 294.29 Thousand | 1.41 Million | 314.89 Thousand | 370.92 Thousand |
| Selling, General and Administrative Expenses | 334.63 Thousand | 348.15 Thousand | 294.29 Thousand | - | 314.89 Thousand | 370.92 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 334.63 Thousand | 348.15 Thousand | 294.29 Thousand | 1.41 Million | 314.89 Thousand | 370.92 Thousand |
| Operating Income | -317.12 Thousand | -330.64 Thousand | 100.45 Thousand | -564.72 Thousand | -296.46 Thousand | -352.49 Thousand |
| Interest Expense | 3878.00 | 1365.00 | - | 454.66 Thousand | - | 111.24 Thousand |
| Income Tax Expense | 2957.00 | 443.00 | 93.39 Thousand | 454.66 Thousand | 115.46 Thousand | - |
| Earnings before Tax | -321 Thousand | -332.01 Thousand | 239.04 Thousand | -941.52 Thousand | -362.66 Thousand | -520.05 Thousand |
| Net Income | -321 Thousand | -332.01 Thousand | 239.04 Thousand | -941.52 Thousand | -362.66 Thousand | -520.05 Thousand |
| Earnings Per Share Basic | -52.39 | -54.19 | 50.00 | - | -59.19 | -84.88 |
| Earnings Per Share Diluted | -52.39 | -54.19 | 50.00 | - | -59.19 | -84.88 |
| Weighted Average Shares Outstanding | 6127.00 | 6127.00 | 6127.00 | 6127.00 | 6127.00 | 6127.00 |
| Weighted Average Shares Outstanding (Diluted) | 6127.00 | 6127.00 | 6127.00 | 6127.00 | 6127.00 | 6127.00 |
| Gross Margin | 0.95 | 0.95 | 0.94 | 0.95 | 1.00 | 1.00 |
| EBIT Margin | -17.16 | -17.89 | 0.84 | - | -18.76 | -19.12 |
| Profit Margin | -17.42 | -18.01 | 0.57 | -1.99 | -19.68 | -28.21 |
| EBITDA | -316.2 Thousand | -329.72 Thousand | 351.34 Thousand | - | -345.72 Thousand | -352.49 Thousand |
| Earnings Before Tax Margin | -17.21 | -17.94 | 0.24 | -1.19 | -16.08 | -19.12 |
OGC
ACRE
BIO
353810
BAZA3
LCTX